Kite Pharma Reports Fourth Quarter and Full-Year 2015 Financial Results
February 29, 2016 16:01 ET
|
Kite Pharma, Inc.
- Interim KTE-C19 Data, Expected in Second Half of 2016, to Support Planned BLA Filing in Late 2016 and Potential Product Launch in 2017 - ...
Kite Pharma Augments Commercial Leadership Team
February 24, 2016 17:00 ET
|
Kite Pharma, Inc.
SANTA MONICA, Calif., Feb. 24, 2016 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Nasdaq:KITE), a clinical-stage biopharmaceutical company focused on developing engineered autologous cell therapy (eACT™)...
Kite Pharma to Report Fourth Quarter and Full Year 2015 Financial Results on February 29, 2016
February 24, 2016 08:00 ET
|
Kite Pharma, Inc.
SANTA MONICA, Calif., Feb. 24, 2016 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., (Nasdaq:KITE) today announced that it will report fourth quarter and full year 2015 financial results on Monday,...
Kite Pharma to Participate in the 2016 RBC Capital Markets Global Healthcare Conference
February 16, 2016 16:31 ET
|
Kite Pharma, Inc.
SANTA MONICA, Calif., Feb. 16, 2016 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., (Nasdaq:KITE) today announced that David D. Chang, M.D., Ph.D., Executive Vice President, Research and Development,...
Kite Pharma and Leiden University Medical Center Sign Research and License Agreement for T Cell Receptors Targeting HPV-Associated Cancers
January 13, 2016 08:00 ET
|
Kite Pharma, Inc.
SANTA MONICA, Calif., Jan. 13, 2016 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Nasdaq:KITE) today announced that its European subsidiary has entered into a research and license agreement with Leiden...
Kite Pharma Expands Its Clinical and Research Partnership With the National Cancer Institute (NCI) for Next-Generation CAR Programs to Treat B-Cell Malignancies
January 07, 2016 10:26 ET
|
Kite Pharma, Inc.
SANTA MONICA, Calif., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (NASDAQ:KITE) today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the NCI...
Kite Pharma to Present at the 34th Annual J.P. Morgan Healthcare Conference
January 06, 2016 08:00 ET
|
Kite Pharma, Inc.
SANTA MONICA, Calif., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (NASDAQ:KITE) today announced that Arie Belldegrun, M.D., FACS, Chairman, President and Chief Executive Officer, will...
Kite Pharma Appoints Industry Leader Shawn Cline Tomasello as Chief Commercial Officer
December 21, 2015 08:00 ET
|
Kite Pharma, Inc.
SANTA MONICA, Calif., Dec. 21, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (NASDAQ:KITE) today announced that it has appointed Shawn Tomasello to the newly created position of Chief Commercial...
Kite Pharma Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
December 11, 2015 08:00 ET
|
Kite Pharma, Inc.
SANTA MONICA, Calif., Dec. 11, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Nasdaq:KITE) today announced that the underwriters of its previously announced underwritten public offering have exercised...
Kite Pharma Announces Pricing of Public Offering of Common Stock
December 10, 2015 08:00 ET
|
Kite Pharma, Inc.
SANTA MONICA, Calif., Dec. 10, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Nasdaq:KITE) today announced the pricing of an underwritten public offering of 3,625,000 shares of its common stock at a...